151 related articles for article (PubMed ID: 2879655)
1. Neuropeptide Y in multiple endocrine neoplasia: release during surgery for phaeochromocytoma.
Connell JM; Corder R; Asbury J; Macpherson S; Inglis GC; Lowry P; Burt AD; Semple PF
Clin Endocrinol (Oxf); 1987 Jan; 26(1):75-84. PubMed ID: 2879655
[TBL] [Abstract][Full Text] [Related]
2. High permanent plasma adrenaline levels: a marker of adrenal medullary disease in medullary thyroid carcinoma.
Vistelle R; Grulet H; Gibold C; Chaufour-Higel B; Delemer B; Fay R; Delisle MJ; Caron J
Clin Endocrinol (Oxf); 1991 Feb; 34(2):133-8. PubMed ID: 1673649
[TBL] [Abstract][Full Text] [Related]
3. [Bilateral adrenal pheochromocytoma. Diagnosis and follow-up using the clonidine test and measurement of plasma neuropeptide Y concentration].
Eisenhut S; Rascher W; Lang RE
Monatsschr Kinderheilkd; 1990 Sep; 138(9):631-4. PubMed ID: 2233767
[TBL] [Abstract][Full Text] [Related]
4. Release of neuropeptide Y and hemodynamic changes during surgical removal of human pheochromocytomas.
Eurin J; Barthélemy C; Masson F; Maistre G; Soualmia H; Noé E; Sarfati E; Eurin B; Carayon A
Regul Pept; 2000 Jan; 86(1-3):95-102. PubMed ID: 10672908
[TBL] [Abstract][Full Text] [Related]
5. Plasma chromogranin A + B, neuropeptide Y and catecholamines in pheochromocytoma patients.
Gröndal S; Eriksson B; Hamberger B; Theodorsson E
J Intern Med; 1991 May; 229(5):453-6. PubMed ID: 2040871
[TBL] [Abstract][Full Text] [Related]
6. Serotonin (5-hydroxytryptamine) in medullary thyroid carcinoma with or without pheochromocytoma.
Engbaek F
Eur J Cancer Clin Oncol; 1985 Apr; 21(4):469-73. PubMed ID: 2861094
[TBL] [Abstract][Full Text] [Related]
7. Does plasma neuropeptide-Y immunoreactivity in patients with pheochromocytoma depend on hormonal activity of the tumor?
Pruszczyk P; Wocial B; Ignatowska-Switalska H; Feltynowski T; Ellafi M; Januszewicz A; Lapiński M; Zukowska-Grojec Z; Januszewicz W
Clin Chim Acta; 1995 Dec; 243(2):205-12. PubMed ID: 8747495
[No Abstract] [Full Text] [Related]
8. Plasma atrial natriuretic factor and catecholamines before and during excision of pheochromocytoma.
Donckier JE; Michel LA; Collard E; Galanti L; Harvengt C; Berbinschi A; Ketelslegers JM; Buysschaert M
Acta Chir Belg; 1991; 91(2):112-6. PubMed ID: 1676862
[TBL] [Abstract][Full Text] [Related]
9. Plasma neuropeptide Y immunoreactivity influences left ventricular mass in pheochromocytoma.
Kuch-Wocial A; Slubowska K; Kostrubiec M; Pasierski T; Januszewicz W; Switalska H; Wocial B; Pruszczyk P
Clin Chim Acta; 2004 Jul; 345(1-2):43-7. PubMed ID: 15193976
[TBL] [Abstract][Full Text] [Related]
10. Increased plasma immunoreactive neuropeptide Y concentrations in phaeochromocytoma and chronic renal failure.
Takahashi K; Mouri T; Itoi K; Sone M; Ohneda M; Murakami O; Nozuki M; Tachibana Y; Yoshinaga K
J Hypertens; 1987 Dec; 5(6):749-53. PubMed ID: 3429875
[TBL] [Abstract][Full Text] [Related]
11. [Ectopic hormone formation in multiple endocrine type IIa neoplasia (author's transl)].
Weber T; Cordes U; Eberle S; Rothmund M; Krause U; Beyer J
Dtsch Med Wochenschr; 1982 Feb; 107(7):252-6. PubMed ID: 6120065
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide Y as a plasma marker for phaeochromocytoma, ganglioneuroblastoma and neuroblastoma.
Mouri T; Sone M; Takahashi K; Itoi K; Totsune K; Hayashi Y; Hasegawa S; Ohneda M; Murakami O; Miura Y
Clin Sci (Lond); 1992 Aug; 83(2):205-11. PubMed ID: 1327637
[TBL] [Abstract][Full Text] [Related]
13. Parallel changes of atrial natriuretic factor and catecholamines during surgery for pheochromocytoma.
Donckier J; Michel L; Collard E; Berbinschi A; Ketelslegers JM; Harvengt C; Buysschaert M
Am J Med; 1988 Aug; 85(2):278-9. PubMed ID: 2899974
[No Abstract] [Full Text] [Related]
14. Chromatographic characterisation of the circulating neuropeptide Y immunoreactivity from patients with phaeochromocytoma.
Corder R; Lowry PJ; Emson PC; Gaillard RC
Regul Pept; 1985 Mar; 10(2-3):91-7. PubMed ID: 3838816
[TBL] [Abstract][Full Text] [Related]
15. Multiple endocrine neoplasia presenting as phaeochromocytoma during pregnancy.
van der Vaart CH; Heringa MP; Dullaart RP; Aarnoudse JG
Br J Obstet Gynaecol; 1993 Dec; 100(12):1144-5. PubMed ID: 7905285
[No Abstract] [Full Text] [Related]
16. Neuropeptide Y in phaeochromocytomas and ganglioneuroblastomas.
Adrian TE; Allen JM; Terenghi G; Bacarese-Hamilton AJ; Brown MJ; Polak JM; Bloom SR
Lancet; 1983 Sep; 2(8349):540-2. PubMed ID: 6136694
[TBL] [Abstract][Full Text] [Related]
17. Pheochromocytoma associated with nocturnal hypertension.
Ishiyama Y; Ohgi T; Kita T; Sasaki A; Kitamura K; Kida O; Kawasaki T; Eto T
Intern Med; 1993 Oct; 32(10):781-3. PubMed ID: 8012072
[TBL] [Abstract][Full Text] [Related]
18. Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas.
Grouzmann E; Gicquel C; Plouin PF; Schlumberger M; Comoy E; Bohuon C
Cancer; 1990 Oct; 66(8):1833-5. PubMed ID: 2208039
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y-like immunoreactivity in adrenaline cells of adrenal medulla and in tumors and plasma of pheochromocytoma patients.
Lundberg JM; Hökfelt T; Hemsén A; Theodorsson-Norheim E; Pernow J; Hamberger B; Goldstein M
Regul Pept; 1986 Jan; 13(2):169-82. PubMed ID: 3513267
[TBL] [Abstract][Full Text] [Related]
20. Bilateral subtotal adrenal resection for bilateral pheochromocytomas in multiple endocrine neoplasia, type IIa: a case report.
van Heerden JA; Sizemore GW; Carney JA; Brennan MD; Sheps SG
Surgery; 1985 Aug; 98(2):363-6. PubMed ID: 2862712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
